security check required facebookjoin or log into facebook   email or phonepasswordforgot accountlog indo you want to join facebooksign upsign upsecurity checkplease enter the text belowcant read the text abovetry another text or an audio captchatext in the boxwhats thissecurity checkthis is a standard security test that we use to prevent spammers from creating fake accounts and spamming userssubmitenglish usespañolfrançais franceالعربيةportuguês brasilitaliano한국어deutschहिन्दीmessengerfacebook litepeopleplacesgameslocationscelebritiesmarketplacegroupsrecipesmomentsinstagramaboutcreate adcreate pagedeveloperscareersprivacycookiesad choicestermssettingsactivity log facebook     francesco de rubertis  wikipedia francesco de rubertis from wikipedia the free encyclopedia jump to navigation search francesco de rubertis born  january   age  italy alma mater university of pavia ba university of geneva phd occupation partner at medicxi spouses sandra henchoz de rubertis francesco de rubertis born january   is a partner at medicxi a venture capital firm with offices in london jersey and geneva having cofounded the firm in february  prior to that he was a partner at another venture capital firm index ventures having led the firm’s efforts to establish its life sciences practice after joining in  contents  early life and education  career  external links  references early life and educationedit de rubertis was born in italy he graduated from the university of pavia with a bachelor of arts in genetics and microbiology before earning a phd in molecular biology from the university of geneva where he also met his wife sandra henchoz who was a fellow student de rubertis engaged in postdoctoral research in molecular genetics at the whitehead institute at massachusetts institute of technology mit and later earned the chartered financial analyst cfa designation careeredit after his postdoctoral work at mit in  de rubertis moved back to geneva where he joined index ventures and helped cofound the firm’s life sciences practice in  he moved to london site of another index office where he continues to reside de rubertis is responsible for all of index ventures’ investments in the life sciences he has served on the boards of directors of many companies including addex therapeutics six adxn cellzome acquired by glaxosmithkline for  million  genmab nasdaq copenhagen gen molecular partners six moln pangenetics acquired by abbott laboratories and parallele bioscience acquired by affymetrix in  de rubertis spearheaded the launch of index ventures’  million life sciences fund in partnership with glaxosmithkline gsk and johnson  johnson jj to invest in earlystage biotechnology companies  de rubertis is the author of several publications in international scientific journals in  de rubertis was named by bioworld as one of  movers and shakers predicted to shape the biotechnology industry over the next two decades  in october  de rubertis was named by xconomy as one of  of “young and proven” biotech venture capitalists de rubertis is a member of the strategic advisory board of the university of geneva external linksedit medicxi website index ventures website francesco de rubertis on twitter referencesedit  jj and gsk join medicxi’s european life sciences push ft february     veni vidi vc pdf university of geneva student magazine november     executive profile bloomberg businessweek may     veni vidi vc pdf university of geneva student magazine november     gsk acquires cellzome  eurobiotechnologynews may     gsk press release glaxosmithkline may     index launches its first life sciences fund m and partnering with glaxo and johnson  johnson techcrunch march     google scholar search francesco de rubertis   the future is here who will shape biotech over the next  years bioworld says… pdf bioworld th anniversary edition    who will survive the biotech vc downturn the young and the proven xconomy october     index ventures partner bio francesco de rubertis  retrieved from httpsenwikipediaorgwindexphptitlefrancescoderubertisoldid categories  birthsliving peopleventure capitalistsitalian businesspeopleuniversity of pavia alumniuniversity of geneva alumnihidden categories articles with hcards navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  june  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view francesco de rubertis  wikipedia francesco de rubertis from wikipedia the free encyclopedia jump to navigation search francesco de rubertis born  january   age  italy alma mater university of pavia ba university of geneva phd occupation partner at medicxi spouses sandra henchoz de rubertis francesco de rubertis born january   is a partner at medicxi a venture capital firm with offices in london jersey and geneva having cofounded the firm in february  prior to that he was a partner at another venture capital firm index ventures having led the firm’s efforts to establish its life sciences practice after joining in  contents  early life and education  career  external links  references early life and educationedit de rubertis was born in italy he graduated from the university of pavia with a bachelor of arts in genetics and microbiology before earning a phd in molecular biology from the university of geneva where he also met his wife sandra henchoz who was a fellow student de rubertis engaged in postdoctoral research in molecular genetics at the whitehead institute at massachusetts institute of technology mit and later earned the chartered financial analyst cfa designation careeredit after his postdoctoral work at mit in  de rubertis moved back to geneva where he joined index ventures and helped cofound the firm’s life sciences practice in  he moved to london site of another index office where he continues to reside de rubertis is responsible for all of index ventures’ investments in the life sciences he has served on the boards of directors of many companies including addex therapeutics six adxn cellzome acquired by glaxosmithkline for  million  genmab nasdaq copenhagen gen molecular partners six moln pangenetics acquired by abbott laboratories and parallele bioscience acquired by affymetrix in  de rubertis spearheaded the launch of index ventures’  million life sciences fund in partnership with glaxosmithkline gsk and johnson  johnson jj to invest in earlystage biotechnology companies  de rubertis is the author of several publications in international scientific journals in  de rubertis was named by bioworld as one of  movers and shakers predicted to shape the biotechnology industry over the next two decades  in october  de rubertis was named by xconomy as one of  of “young and proven” biotech venture capitalists de rubertis is a member of the strategic advisory board of the university of geneva external linksedit medicxi website index ventures website francesco de rubertis on twitter referencesedit  jj and gsk join medicxi’s european life sciences push ft february     veni vidi vc pdf university of geneva student magazine november     executive profile bloomberg businessweek may     veni vidi vc pdf university of geneva student magazine november     gsk acquires cellzome  eurobiotechnologynews may     gsk press release glaxosmithkline may     index launches its first life sciences fund m and partnering with glaxo and johnson  johnson techcrunch march     google scholar search francesco de rubertis   the future is here who will shape biotech over the next  years bioworld says… pdf bioworld th anniversary edition    who will survive the biotech vc downturn the young and the proven xconomy october     index ventures partner bio francesco de rubertis  retrieved from httpsenwikipediaorgwindexphptitlefrancescoderubertisoldid categories  birthsliving peopleventure capitalistsitalian businesspeopleuniversity of pavia alumniuniversity of geneva alumnihidden categories articles with hcards navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  june  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view francesco de rubertis  wikipedia francesco de rubertis from wikipedia the free encyclopedia jump to navigation search francesco de rubertis born  january   age  italy alma mater university of pavia ba university of geneva phd occupation partner at medicxi spouses sandra henchoz de rubertis francesco de rubertis born january   is a partner at medicxi a venture capital firm with offices in london jersey and geneva having cofounded the firm in february  prior to that he was a partner at another venture capital firm index ventures having led the firm’s efforts to establish its life sciences practice after joining in  contents  early life and education  career  external links  references early life and educationedit de rubertis was born in italy he graduated from the university of pavia with a bachelor of arts in genetics and microbiology before earning a phd in molecular biology from the university of geneva where he also met his wife sandra henchoz who was a fellow student de rubertis engaged in postdoctoral research in molecular genetics at the whitehead institute at massachusetts institute of technology mit and later earned the chartered financial analyst cfa designation careeredit after his postdoctoral work at mit in  de rubertis moved back to geneva where he joined index ventures and helped cofound the firm’s life sciences practice in  he moved to london site of another index office where he continues to reside de rubertis is responsible for all of index ventures’ investments in the life sciences he has served on the boards of directors of many companies including addex therapeutics six adxn cellzome acquired by glaxosmithkline for  million  genmab nasdaq copenhagen gen molecular partners six moln pangenetics acquired by abbott laboratories and parallele bioscience acquired by affymetrix in  de rubertis spearheaded the launch of index ventures’  million life sciences fund in partnership with glaxosmithkline gsk and johnson  johnson jj to invest in earlystage biotechnology companies  de rubertis is the author of several publications in international scientific journals in  de rubertis was named by bioworld as one of  movers and shakers predicted to shape the biotechnology industry over the next two decades  in october  de rubertis was named by xconomy as one of  of “young and proven” biotech venture capitalists de rubertis is a member of the strategic advisory board of the university of geneva external linksedit medicxi website index ventures website francesco de rubertis on twitter referencesedit  jj and gsk join medicxi’s european life sciences push ft february     veni vidi vc pdf university of geneva student magazine november     executive profile bloomberg businessweek may     veni vidi vc pdf university of geneva student magazine november     gsk acquires cellzome  eurobiotechnologynews may     gsk press release glaxosmithkline may     index launches its first life sciences fund m and partnering with glaxo and johnson  johnson techcrunch march     google scholar search francesco de rubertis   the future is here who will shape biotech over the next  years bioworld says… pdf bioworld th anniversary edition    who will survive the biotech vc downturn the young and the proven xconomy october     index ventures partner bio francesco de rubertis  retrieved from httpsenwikipediaorgwindexphptitlefrancescoderubertisoldid categories  birthsliving peopleventure capitalistsitalian businesspeopleuniversity of pavia alumniuniversity of geneva alumnihidden categories articles with hcards navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  june  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view francesco de rubertis  wikipedia francesco de rubertis from wikipedia the free encyclopedia jump to navigation search francesco de rubertis born  january   age  italy alma mater university of pavia ba university of geneva phd occupation partner at medicxi spouses sandra henchoz de rubertis francesco de rubertis born january   is a partner at medicxi a venture capital firm with offices in london jersey and geneva having cofounded the firm in february  prior to that he was a partner at another venture capital firm index ventures having led the firm’s efforts to establish its life sciences practice after joining in  contents  early life and education  career  external links  references early life and educationedit de rubertis was born in italy he graduated from the university of pavia with a bachelor of arts in genetics and microbiology before earning a phd in molecular biology from the university of geneva where he also met his wife sandra henchoz who was a fellow student de rubertis engaged in postdoctoral research in molecular genetics at the whitehead institute at massachusetts institute of technology mit and later earned the chartered financial analyst cfa designation careeredit after his postdoctoral work at mit in  de rubertis moved back to geneva where he joined index ventures and helped cofound the firm’s life sciences practice in  he moved to london site of another index office where he continues to reside de rubertis is responsible for all of index ventures’ investments in the life sciences he has served on the boards of directors of many companies including addex therapeutics six adxn cellzome acquired by glaxosmithkline for  million  genmab nasdaq copenhagen gen molecular partners six moln pangenetics acquired by abbott laboratories and parallele bioscience acquired by affymetrix in  de rubertis spearheaded the launch of index ventures’  million life sciences fund in partnership with glaxosmithkline gsk and johnson  johnson jj to invest in earlystage biotechnology companies  de rubertis is the author of several publications in international scientific journals in  de rubertis was named by bioworld as one of  movers and shakers predicted to shape the biotechnology industry over the next two decades  in october  de rubertis was named by xconomy as one of  of “young and proven” biotech venture capitalists de rubertis is a member of the strategic advisory board of the university of geneva external linksedit medicxi website index ventures website francesco de rubertis on twitter referencesedit  jj and gsk join medicxi’s european life sciences push ft february     veni vidi vc pdf university of geneva student magazine november     executive profile bloomberg businessweek may     veni vidi vc pdf university of geneva student magazine november     gsk acquires cellzome  eurobiotechnologynews may     gsk press release glaxosmithkline may     index launches its first life sciences fund m and partnering with glaxo and johnson  johnson techcrunch march     google scholar search francesco de rubertis   the future is here who will shape biotech over the next  years bioworld says… pdf bioworld th anniversary edition    who will survive the biotech vc downturn the young and the proven xconomy october     index ventures partner bio francesco de rubertis  retrieved from httpsenwikipediaorgwindexphptitlefrancescoderubertisoldid categories  birthsliving peopleventure capitalistsitalian businesspeopleuniversity of pavia alumniuniversity of geneva alumnihidden categories articles with hcards navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  june  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view francesco derubertis fderubertis  twitter skip to content home home home current page moments moments moments current page search query search twitter saved searches remove in this conversation verified accountprotected tweets  suggested users verified accountprotected tweets  verified accountprotected tweets  language english bahasa indonesia bahasa melayu català čeština dansk deutsch english uk español filipino français hrvatski italiano magyar nederlands norsk polski português română slovenčina suomi svenska tiếng việt türkçe ελληνικά български език русский српски українська мова עִבְרִית العربية فارسی मराठी हिन्दी বাংলা ગુજરાતી தமிழ் ಕನ್ನಡ ภาษาไทย 한국어   繁體 have an account log in have an account remember me · forgot password new to twitter sign up francesco derubertis fderubertis tweets tweets current page  following following  followers followers  likes likes    more likes unmute fderubertis mute fderubertis follow following unfollow blocked unblock pending cancel francesco derubertis fderubertis venture capitalist medicxi investing in life sciences pharma biotechnology london  geneva joined may   photos and videos photos and videos tweets tweets tweets current page tweets  replies media you blocked fderubertis are you sure you want to view these tweets viewing tweets wont unblock fderubertis yes view profile close francesco derubertis followed francesco derubertis retweeted labiotecheu‏ labiotecheu jul  more copy link to tweet embed tweet meet the gynecologist at the helm of geneva’s star biotech women obseva pregnancy obseva httpbitlytbbid pictwittercomgalknbpbm  replies  retweets  likes reply retweet  retweeted  like liked thanks twitter will use this to make your timeline better undo francesco derubertis retweeted medicxi‏ medicxi jun  more copy link to tweet embed tweet congrats to our friends at atlas on their m atlas venture fund xi httpslifescivccomatlascrankselevenfundxi … great strategy great execution lifescivc  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted labiotecheu‏ labiotecheu jun  more copy link to tweet embed tweet discussing the virtual biotech model with xo cofounder trevor baglin httpbitlyrztmm  academicpictwittercommfgnlwhsm  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted susan schaeffer‏ biotechsusan jun  more copy link to tweet embed tweet investing in maturity medicxi thinks europe is ready for a latestage crossover fundhttpswwwbiocenturycombiocenturyfinancewhymedicxithinkseuropereadylatestagecrossoverfund …  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted saul klein‏ cape jun  more copy link to tweet embed tweet saul klein retweeted index ventures congrats medicxi team  keeping pushing the envelope in life science innovation  go fderubertis kevin david rich and teamhttpstwittercomindexventuresstatus … saul klein added index ventures indexventures alphabet life sciences arm verily and novartis back new m medicxi biotech fund congrats fderubertis  team httpswwwftcomcontentadbceafdbbbftcampengagefcapifwebappfchannelsignalffbb …  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted reuters health‏verified account reutershealth jun  more copy link to tweet embed tweet google bets on european biotech drugs backs new fundhttpreutrsritiyo   replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted mike ward‏ scripmikeward jun  more copy link to tweet embed tweet google joins novartis backing medicxi’s new m latestage fund biotech pharma medtech vc medicxihttpsscrippharmamedtechbicomarticlesgooglejoinsnovartisbackingmedicxisnewmlatestagefund …  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted mike ward‏ scripmikeward jun  more copy link to tweet embed tweet alphabets verilylife joins novartis  eif to cornerstone new m medicxi growth fund mg biotech pharma medtech  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted simon bayly‏ simonbayly jun  more copy link to tweet embed tweet simon bayly retweeted john carroll new late stage fund for medicxi congrats fderubertis medicxikevin sciencescanner et alhttpstwittercomjohncendptsstatus … simon bayly added john carrollverified account johncendpts with nvs and google jumping in medicxi unveils a m latestage biotech fund with a transatlantic scope httpsendptscomwithnovartisandgooglejumpinginmedicxiunveilsamlatestagebiotechfundwithatransatlanticscope …  replies  retweets  like reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted john carroll‏verified account johncendpts jun  more copy link to tweet embed tweet with nvs and google jumping in medicxi unveils a m latestage biotech fund with a transatlantic scopehttpsendptscomwithnovartisandgooglejumpinginmedicxiunveilsamlatestagebiotechfundwithatransatlanticscope …  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted scott gottlieb md‏verified account sgottliebfda jun  more copy link to tweet embed tweet replying to sgottliebfda were facing an opioid epidemic – a public health crisis and we must take all necessary steps to reduce scope of opioid misuse and abuse  replies  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted cnn breaking news‏verified account cnnbrk jun  more copy link to tweet embed tweet usda calls for drugmaker to remove its powerful opioid opana er from market citing consequences of abuse httpcnnitszsec pictwittercomkezmvlg  replies  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted binyamin appelbaum‏verified account bcappelbaum may  more copy link to tweet embed tweet binyamin appelbaum retweeted yannis koutsomitis if you wrote a piece about trumps successful foreign trip you should sit quietly contemplating this quote for the next few hourshttpstwittercomyannikoutsstatus … binyamin appelbaum added yannis koutsomitisverified account yannikouts merkel we cant rely on the us anymore i have experienced this in the last days we europeans should take destiny in our own hands bild  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo francesco derubertis retweeted vala afshar‏verified account valaafshar may  more copy link to tweet embed tweet stare at the white dot for  seconds then look at van goghs starry nightpictwittercomwahyvrunj  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo francesco derubertis retweeted brad loncar‏verified account bradloncar may  more copy link to tweet embed tweet incy jakafi ramppictwittercomfgzerxktx  reply  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted fred destin‏ fdestin may  more copy link to tweet embed tweet fred destin retweeted brian omalley yes  investors are good at detecting trends but being right five years too early is absolutely useless in terms of driving returnshttpstwittercomomalstatus … fred destin added brian omalley omal starting to think the hardest part of venture is not calling what will happen but instead when it will happen  replies  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted medicxi‏ medicxi may  more copy link to tweet embed tweet z factor is built on a unique structural insight from founder jhuntingtonucam together with some neat in silico drug design  replies  retweet  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted medicxi‏ medicxi may  more copy link to tweet embed tweet delighted to lead new investment round in z factor  huge progress towards a cure of aat deficiencyhttpswwwenterprisecamacuknewscambridgeenterprisespinoutcompanyzfactorannouncesmillionseriesafundingtobringlungtreatmenttotheclinicwqnustxoatwitter …  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted david allen green‏ davidallengreen apr  more copy link to tweet embed tweet uk we want brexit brexit means brexit eu here is brexit brexit means brexit uk you are ganging up on us so unfair  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo francesco derubertis retweeted michael gilman‏verified account michaelgilman apr  more copy link to tweet embed tweet michael gilman retweeted maxine gilman it great to be  years old and still making your mother happyhttpstwittercomseeseenstatus … michael gilman added maxine gilman seeseen replying to michaelgilman so proud im going to burst m  reply  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo fderubertis hasnt tweeted yet back to top ↑ loading seems to be taking a while twitter may be over capacity or experiencing a momentary hiccup try again or visit twitter status for more information new to twitter sign up now to get your own personalized timeline sign up you may also like · refresh false   twitter about help center terms privacy policy cookies ads info close choose a trend location dismiss close previous next close go to a persons profile saved searches remove in this conversation verified accountprotected tweets  suggested users verified accountprotected tweets  verified accountprotected tweets  close promote this tweet close block cancel block add a location to your tweets when you tweet with a location twitter stores that location you can switch location onoff before each tweet and always have the option to delete your location history learn more turn location on not now close share location results from send close your lists close create a new list list name description under  characters optional privacy public · anyone can follow this list private · only you can access this list save list close close copy link to tweet heres the url for this tweet copy it to easily share with friends close embed this tweet embed this video add this tweet to your website by copying the code below learn more add this video to your website by copying the code below learn more hmm there was a problem reaching the server try again include parent tweet include media by embedding twitter content in your website or app you are agreeing to the twitter developer agreement and developer policy preview close why youre seeing this ad close log in to twitter remember me · forgot password dont have an account sign up » close sign up for twitter not on twitter sign up tune into the things you care about and get updates as they happen sign up have an account log in » close twoway sending and receiving short codes country code for customers of united states  any canada  any united kingdom  vodafone orange  o brazil  nextel tim haiti  digicel voila ireland  vodafone o india  bharti airtel videocon reliance indonesia  axis  telkomsel indosat xl axiata italy  wind  vodafone » see sms short codes for other countries close confirmation close   close skip all welcome home this timeline is where you’ll spend most of your time getting instant updates about what matters to you tweets not working for you hover over the profile pic and click the following button to unfollow any account say a lot with a little when you see a tweet you love tap the heart — it lets the person who wrote it know you shared the love spread the word the fastest way to share someone else’s tweet with your followers is with a retweet tap the icon to send it instantly join the conversation add your thoughts about any tweet with a reply find a topic you’re passionate about and jump right in learn the latest get instant insight into what people are talking about now get more of what you love follow more accounts to get instant updates about topics you care about find whats happening see the latest conversations about any topic instantly never miss a moment catch up instantly on the best stories happening as they unfold back next next tweet from user francesco de rubertis  wikipedia francesco de rubertis from wikipedia the free encyclopedia jump to navigation search francesco de rubertis born  january   age  italy alma mater university of pavia ba university of geneva phd occupation partner at medicxi spouses sandra henchoz de rubertis francesco de rubertis born january   is a partner at medicxi a venture capital firm with offices in london jersey and geneva having cofounded the firm in february  prior to that he was a partner at another venture capital firm index ventures having led the firm’s efforts to establish its life sciences practice after joining in  contents  early life and education  career  external links  references early life and educationedit de rubertis was born in italy he graduated from the university of pavia with a bachelor of arts in genetics and microbiology before earning a phd in molecular biology from the university of geneva where he also met his wife sandra henchoz who was a fellow student de rubertis engaged in postdoctoral research in molecular genetics at the whitehead institute at massachusetts institute of technology mit and later earned the chartered financial analyst cfa designation careeredit after his postdoctoral work at mit in  de rubertis moved back to geneva where he joined index ventures and helped cofound the firm’s life sciences practice in  he moved to london site of another index office where he continues to reside de rubertis is responsible for all of index ventures’ investments in the life sciences he has served on the boards of directors of many companies including addex therapeutics six adxn cellzome acquired by glaxosmithkline for  million  genmab nasdaq copenhagen gen molecular partners six moln pangenetics acquired by abbott laboratories and parallele bioscience acquired by affymetrix in  de rubertis spearheaded the launch of index ventures’  million life sciences fund in partnership with glaxosmithkline gsk and johnson  johnson jj to invest in earlystage biotechnology companies  de rubertis is the author of several publications in international scientific journals in  de rubertis was named by bioworld as one of  movers and shakers predicted to shape the biotechnology industry over the next two decades  in october  de rubertis was named by xconomy as one of  of “young and proven” biotech venture capitalists de rubertis is a member of the strategic advisory board of the university of geneva external linksedit medicxi website index ventures website francesco de rubertis on twitter referencesedit  jj and gsk join medicxi’s european life sciences push ft february     veni vidi vc pdf university of geneva student magazine november     executive profile bloomberg businessweek may     veni vidi vc pdf university of geneva student magazine november     gsk acquires cellzome  eurobiotechnologynews may     gsk press release glaxosmithkline may     index launches its first life sciences fund m and partnering with glaxo and johnson  johnson techcrunch march     google scholar search francesco de rubertis   the future is here who will shape biotech over the next  years bioworld says… pdf bioworld th anniversary edition    who will survive the biotech vc downturn the young and the proven xconomy october     index ventures partner bio francesco de rubertis  retrieved from httpsenwikipediaorgwindexphptitlefrancescoderubertisoldid categories  birthsliving peopleventure capitalistsitalian businesspeopleuniversity of pavia alumniuniversity of geneva alumnihidden categories articles with hcards navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  june  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view francesco de rubertis  wikivisually wikivisually the entire wiki with video and photo galleriesfind something interesting to watch in seconds featured articles  · video picker · language · hover over links in text for more info click links in text for more info francesco de rubertis from wikipedia the free encyclopedia jump to navigation search francesco de rubertis born  january   age  italy alma mater university of pavia ba university of geneva phd occupation partner at medicxi spouses sandra henchoz de rubertis francesco de rubertis born january   is a partner at medicxi a venture capital firm with offices in london jersey and geneva having cofounded the firm in february  prior to that he was a partner at another venture capital firm index ventures having led the firm’s efforts to establish its life sciences practice after joining in  contents  early life and education  career  external links  references early life and educationedit de rubertis was born in italy he graduated from the university of pavia with a bachelor of arts in genetics and microbiology before earning a phd in molecular biology from the university of geneva where he also met his wife sandra henchoz who was a fellow student de rubertis engaged in postdoctoral research in molecular genetics at the whitehead institute at massachusetts institute of technology mit and later earned the chartered financial analyst cfa designation careeredit after his postdoctoral work at mit in  de rubertis moved back to geneva where he joined index ventures and helped cofound the firm’s life sciences practice in  he moved to london site of another index office where he continues to reside de rubertis is responsible for all of index ventures’ investments in the life sciences he has served on the boards of directors of many companies including addex therapeutics six adxn cellzome acquired by glaxosmithkline for  million  genmab nasdaq copenhagen gen molecular partners six moln pangenetics acquired by abbott laboratories and parallele bioscience acquired by affymetrix in  de rubertis spearheaded the launch of index ventures’  million life sciences fund in partnership with glaxosmithkline gsk and johnson  johnson jj to invest in earlystage biotechnology companies  de rubertis is the author of several publications in international scientific journals in  de rubertis was named by bioworld as one of  movers and shakers predicted to shape the biotechnology industry over the next two decades  in october  de rubertis was named by xconomy as one of  of “young and proven” biotech venture capitalists de rubertis is a member of the strategic advisory board of the university of geneva external linksedit medicxi website index ventures website francesco de rubertis on twitter referencesedit  jj and gsk join medicxi’s european life sciences push ft february     veni vidi vc pdf university of geneva student magazine november     executive profile bloomberg businessweek may     veni vidi vc pdf university of geneva student magazine november     gsk acquires cellzome  eurobiotechnologynews may     gsk press release glaxosmithkline may     index launches its first life sciences fund m and partnering with glaxo and johnson  johnson techcrunch march     google scholar search francesco de rubertis   the future is here who will shape biotech over the next  years bioworld says… pdf bioworld th anniversary edition    who will survive the biotech vc downturn the young and the proven xconomy october     index ventures partner bio francesco de rubertis  retrieved from httpsenwikipediaorgwindexphptitlefrancescoderubertisoldid categories  birthsliving peopleventure capitalistsitalian businesspeopleuniversity of pavia alumniuniversity of geneva alumnihidden categories articles with hcards navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  june  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view hide videos list of images loading microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft francesco de rubertis medicxi ventures profile  biography  bloomberg feedback francesco de rubertis gen partnercofounder medicxi ventures career history gen partnercofounder medicxi ventures present senior partner index ventures unknown index ventures unknown chairman pangenetics bv former doctoral research whitehead institute former massachusetts institute of technology former show more website wwwmedicxiventurescom corporate information address  burlington gardens london ws ep united kingdom phone  fax  web url wwwmedicxiventurescom from the web personal information education university of geneva phd university of pavia bachelors degree awards  publications certificates chartered financial analyst cfa memberships board memberships hamilton board member present tm pharma as board member present egalet sa board member present glycovaxyn sa board member present sequenta inc board member present normoxys inc board member present structural genonmix board member present ingenium ingenieria y domotica sl board member present university of geneva board member present profibrix bv board member present bioxell spa board member present molecular partners ag board member present minerva neurosciences inc board member present addex pharmaceuticals ltd board member  bioxell spa board member  pangenetics bv chairman former cellzome ag board member former parallele bioscience board member former genmab as board member former versartis inc board member unknown show more sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data francesco derubertis fderubertis  twitter skip to content home home home current page moments moments moments current page search query search twitter saved searches remove in this conversation verified accountprotected tweets  suggested users verified accountprotected tweets  verified accountprotected tweets  language english bahasa indonesia bahasa melayu català čeština dansk deutsch english uk español filipino français hrvatski italiano magyar nederlands norsk polski português română slovenčina suomi svenska tiếng việt türkçe ελληνικά български език русский српски українська мова עִבְרִית العربية فارسی मराठी हिन्दी বাংলা ગુજરાતી தமிழ் ಕನ್ನಡ ภาษาไทย 한국어   繁體 have an account log in have an account remember me · forgot password new to twitter sign up francesco derubertis fderubertis tweets tweets current page  following following  followers followers  likes likes    more likes unmute fderubertis mute fderubertis follow following unfollow blocked unblock pending cancel francesco derubertis fderubertis venture capitalist medicxi investing in life sciences pharma biotechnology london  geneva joined may   photos and videos photos and videos tweets tweets tweets current page tweets  replies media you blocked fderubertis are you sure you want to view these tweets viewing tweets wont unblock fderubertis yes view profile close francesco derubertis followed francesco derubertis retweeted labiotecheu‏ labiotecheu jul  more copy link to tweet embed tweet meet the gynecologist at the helm of geneva’s star biotech women obseva pregnancy obseva httpbitlytbbid pictwittercomgalknbpbm  replies  retweets  likes reply retweet  retweeted  like liked thanks twitter will use this to make your timeline better undo francesco derubertis retweeted medicxi‏ medicxi jun  more copy link to tweet embed tweet congrats to our friends at atlas on their m atlas venture fund xi httpslifescivccomatlascrankselevenfundxi … great strategy great execution lifescivc  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted labiotecheu‏ labiotecheu jun  more copy link to tweet embed tweet discussing the virtual biotech model with xo cofounder trevor baglin httpbitlyrztmm  academicpictwittercommfgnlwhsm  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted susan schaeffer‏ biotechsusan jun  more copy link to tweet embed tweet investing in maturity medicxi thinks europe is ready for a latestage crossover fundhttpswwwbiocenturycombiocenturyfinancewhymedicxithinkseuropereadylatestagecrossoverfund …  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted saul klein‏ cape jun  more copy link to tweet embed tweet saul klein retweeted index ventures congrats medicxi team  keeping pushing the envelope in life science innovation  go fderubertis kevin david rich and teamhttpstwittercomindexventuresstatus … saul klein added index ventures indexventures alphabet life sciences arm verily and novartis back new m medicxi biotech fund congrats fderubertis  team httpswwwftcomcontentadbceafdbbbftcampengagefcapifwebappfchannelsignalffbb …  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted reuters health‏verified account reutershealth jun  more copy link to tweet embed tweet google bets on european biotech drugs backs new fundhttpreutrsritiyo   replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted mike ward‏ scripmikeward jun  more copy link to tweet embed tweet google joins novartis backing medicxi’s new m latestage fund biotech pharma medtech vc medicxihttpsscrippharmamedtechbicomarticlesgooglejoinsnovartisbackingmedicxisnewmlatestagefund …  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted mike ward‏ scripmikeward jun  more copy link to tweet embed tweet alphabets verilylife joins novartis  eif to cornerstone new m medicxi growth fund mg biotech pharma medtech  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted simon bayly‏ simonbayly jun  more copy link to tweet embed tweet simon bayly retweeted john carroll new late stage fund for medicxi congrats fderubertis medicxikevin sciencescanner et alhttpstwittercomjohncendptsstatus … simon bayly added john carrollverified account johncendpts with nvs and google jumping in medicxi unveils a m latestage biotech fund with a transatlantic scope httpsendptscomwithnovartisandgooglejumpinginmedicxiunveilsamlatestagebiotechfundwithatransatlanticscope …  replies  retweets  like reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted john carroll‏verified account johncendpts jun  more copy link to tweet embed tweet with nvs and google jumping in medicxi unveils a m latestage biotech fund with a transatlantic scopehttpsendptscomwithnovartisandgooglejumpinginmedicxiunveilsamlatestagebiotechfundwithatransatlanticscope …  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted scott gottlieb md‏verified account sgottliebfda jun  more copy link to tweet embed tweet replying to sgottliebfda were facing an opioid epidemic – a public health crisis and we must take all necessary steps to reduce scope of opioid misuse and abuse  replies  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted cnn breaking news‏verified account cnnbrk jun  more copy link to tweet embed tweet usda calls for drugmaker to remove its powerful opioid opana er from market citing consequences of abuse httpcnnitszsec pictwittercomkezmvlg  replies  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted binyamin appelbaum‏verified account bcappelbaum may  more copy link to tweet embed tweet binyamin appelbaum retweeted yannis koutsomitis if you wrote a piece about trumps successful foreign trip you should sit quietly contemplating this quote for the next few hourshttpstwittercomyannikoutsstatus … binyamin appelbaum added yannis koutsomitisverified account yannikouts merkel we cant rely on the us anymore i have experienced this in the last days we europeans should take destiny in our own hands bild  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo francesco derubertis retweeted vala afshar‏verified account valaafshar may  more copy link to tweet embed tweet stare at the white dot for  seconds then look at van goghs starry nightpictwittercomwahyvrunj  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo francesco derubertis retweeted brad loncar‏verified account bradloncar may  more copy link to tweet embed tweet incy jakafi ramppictwittercomfgzerxktx  reply  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted fred destin‏ fdestin may  more copy link to tweet embed tweet fred destin retweeted brian omalley yes  investors are good at detecting trends but being right five years too early is absolutely useless in terms of driving returnshttpstwittercomomalstatus … fred destin added brian omalley omal starting to think the hardest part of venture is not calling what will happen but instead when it will happen  replies  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted medicxi‏ medicxi may  more copy link to tweet embed tweet z factor is built on a unique structural insight from founder jhuntingtonucam together with some neat in silico drug design  replies  retweet  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted medicxi‏ medicxi may  more copy link to tweet embed tweet delighted to lead new investment round in z factor  huge progress towards a cure of aat deficiencyhttpswwwenterprisecamacuknewscambridgeenterprisespinoutcompanyzfactorannouncesmillionseriesafundingtobringlungtreatmenttotheclinicwqnustxoatwitter …  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo francesco derubertis retweeted david allen green‏ davidallengreen apr  more copy link to tweet embed tweet uk we want brexit brexit means brexit eu here is brexit brexit means brexit uk you are ganging up on us so unfair  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo francesco derubertis retweeted michael gilman‏verified account michaelgilman apr  more copy link to tweet embed tweet michael gilman retweeted maxine gilman it great to be  years old and still making your mother happyhttpstwittercomseeseenstatus … michael gilman added maxine gilman seeseen replying to michaelgilman so proud im going to burst m  reply  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo fderubertis hasnt tweeted yet back to top ↑ loading seems to be taking a while twitter may be over capacity or experiencing a momentary hiccup try again or visit twitter status for more information new to twitter sign up now to get your own personalized timeline sign up you may also like · refresh false   twitter about help center terms privacy policy cookies ads info close choose a trend location dismiss close previous next close go to a persons profile saved searches remove in this conversation verified accountprotected tweets  suggested users verified accountprotected tweets  verified accountprotected tweets  close promote this tweet close block cancel block add a location to your tweets when you tweet with a location twitter stores that location you can switch location onoff before each tweet and always have the option to delete your location history learn more turn location on not now close share location results from send close your lists close create a new list list name description under  characters optional privacy public · anyone can follow this list private · only you can access this list save list close close copy link to tweet heres the url for this tweet copy it to easily share with friends close embed this tweet embed this video add this tweet to your website by copying the code below learn more add this video to your website by copying the code below learn more hmm there was a problem reaching the server try again include parent tweet include media by embedding twitter content in your website or app you are agreeing to the twitter developer agreement and developer policy preview close why youre seeing this ad close log in to twitter remember me · forgot password dont have an account sign up » close sign up for twitter not on twitter sign up tune into the things you care about and get updates as they happen sign up have an account log in » close twoway sending and receiving short codes country code for customers of united states  any canada  any united kingdom  vodafone orange  o brazil  nextel tim haiti  digicel voila ireland  vodafone o india  bharti airtel videocon reliance indonesia  axis  telkomsel indosat xl axiata italy  wind  vodafone » see sms short codes for other countries close confirmation close   close skip all welcome home this timeline is where you’ll spend most of your time getting instant updates about what matters to you tweets not working for you hover over the profile pic and click the following button to unfollow any account say a lot with a little when you see a tweet you love tap the heart — it lets the person who wrote it know you shared the love spread the word the fastest way to share someone else’s tweet with your followers is with a retweet tap the icon to send it instantly join the conversation add your thoughts about any tweet with a reply find a topic you’re passionate about and jump right in learn the latest get instant insight into what people are talking about now get more of what you love follow more accounts to get instant updates about topics you care about find whats happening see the latest conversations about any topic instantly never miss a moment catch up instantly on the best stories happening as they unfold back next next tweet from user francesco de rubertis  medicxi francesco de rubertis prior to cofounding medicxi  francesco was with index ventures for  years having joined the firm in  to launch its life sciences practice while at index life sciences he spearheaded the creation and adoption of the assetcentric investment strategy and led the growth of the firm at medicxi he also oversees the firm’s operations francesco’s investments include cellzome acquired by glaxosmithkline egalet nasdaq eglt genmab copenhagen genco gensight biologics euronext sight micromet acquired by amgen minerva neurosciences nasdaq nerv molecular partners swiss molnsw pangenetics acquired by abbott parallele biosciences acquired by affymetrix nasdaq affx profibrix acquired by the medicines company versartis nasdaq vsar and several others  francesco received a ba in genetics and microbiology from the university of pavia and a phd in molecular biology from the university of geneva and was then a postdoctoral scientist at the whitehead institute at mit he is a chartered financial analyst and serves on the main board of the university of geneva born livorno italy lives london geneva office london schooled university of pavia university of geneva worked london geneva cambridge massachusetts interests music production rugby opera legal all rights reserved  medicxi